Rocket Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 11/14/2025 | 17.69 M | $57.66 M | 0.00% | 15.93% |
| MAVERICK CAPITAL LTD | 11/14/2025 | 8.47 M | $27.61 M | 1.25% | 7.63% |
| BLACKROCK, INC. | 11/12/2025 | 7.11 M | $23.19 M | -4.23% | 6.41% |
| VANGUARD GROUP INC | 11/07/2025 | 6.89 M | $22.47 M | 12.57% | 6.21% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 3.90 M | $12.73 M | 0.01% | 3.52% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 3.84 M | $12.53 M | -7.24% | 3.46% |
| MORGAN STANLEY | 11/14/2025 | 3.65 M | $11.89 M | 15.08% | 3.29% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 3.57 M | $11.64 M | 52.01% | 3.22% |
| MONACO ASSET MANAGEMENT SAM | 11/10/2025 | 2.89 M | $9.43 M | 538.80% | 2.61% |
| NEWTYN MANAGEMENT, LLC | 11/14/2025 | 2.50 M | $8.16 M | 25.14% | 2.25% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 2.19 M | $7.14 M | 120.56% | 1.97% |
| JPMORGAN CHASE & CO | 11/26/2025 | 2.10 M | $6.84 M | 73.62% | 1.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.91 M | $6.24 M | -5.73% | 1.72% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 1.80 M | $5.85 M | 20.50% | 1.62% |
| STATE STREET CORP | 11/14/2025 | 1.75 M | $5.69 M | -10.21% | 1.57% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.67 M | $5.45 M | 970.76% | 1.51% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 1.61 M | $5.25 M | -6.70% | 1.45% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 1.31 M | $4.28 M | 896.72% | 1.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.27 M | $4.14 M | -19.32% | 1.14% |
| PROSIGHT MANAGEMENT, LP | 11/14/2025 | 1.27 M | $4.13 M | -19.78% | 1.14% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.06 M | $3.46 M | -3.50% | 0.96% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 1.01 M | $3.31 M | -34.48% | 0.91% |
| AQR CAPITAL MANAGEMENT LLC | 11/14/2025 | 873.25 K | $2.85 M | 12.29% | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 850.00 K | $2.77 M | 0.00% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 744.07 K | $2.43 M | 21.03% | 0.67% |
| NORTHERN TRUST CORP | 11/14/2025 | 657.01 K | $2.14 M | -6.32% | 0.59% |
| FEDERATED HERMES, INC. | 11/03/2025 | 627.57 K | $2.05 M | 0.52% | 0.57% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 625.53 K | $2.04 M | 8.59% | 0.56% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 575.80 K | $1.88 M | 108.77% | 0.52% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 555.82 K | $1.81 M | -0.74% | 0.50% |
| UBS GROUP AG | 11/13/2025 | 532.99 K | $1.74 M | -36.28% | 0.48% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 514.92 K | $1.68 M | 10.24% | 0.46% |
| JANE STREET GROUP, LLC | 11/14/2025 | 484.48 K | $1.58 M | 994.43% | 0.44% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 438.38 K | $1.43 M | 128.30% | 0.39% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 11/14/2025 | 434.41 K | $1.42 M | 0.00% | 0.39% |
| PRIVIUM FUND MANAGEMENT B.V. | 11/04/2025 | 432.76 K | $1.41 M | 0.00% | 0.39% |
| M28 CAPITAL MANAGEMENT LP | 11/13/2025 | 385.68 K | $1.26 M | 0.00% | 0.35% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 377.58 K | $1.23 M | -16.95% | 0.34% |
| FMR LLC | 11/13/2025 | 311.70 K | $1.02 M | 17.16% | 0.28% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2025 | 305.44 K | $995.73 K | 11.37% | 0.28% |
| VOSS CAPITAL, LLC | 11/20/2025 | 300.00 K | $978.00 K | -40.00% | 0.27% |
| ROYAL BANK OF CANADA | 11/14/2025 | 280.71 K | $915.00 K | -25.70% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 279.90 K | $912.47 K | -6.29% | 0.25% |
| PDT PARTNERS, LLC | 11/17/2025 | 265.98 K | $867.10 K | 0.00% | 0.24% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 10/20/2025 | 264.43 K | $862.05 K | 252.97% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 245.31 K | $799.72 K | 5.74% | 0.22% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 242.70 K | $791.20 K | -11.81% | 0.22% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/14/2025 | 242.18 K | $789.52 K | 46.75% | 0.22% |
| GSA CAPITAL PARTNERS LLP | 11/07/2025 | 224.28 K | $731.00 K | 502.26% | 0.20% |
| INVESCO LTD. | 11/13/2025 | 222.45 K | $725.20 K | 100.40% | 0.20% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rocket Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 263 institutional investors and hedge funds held shares of Rocket Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 17.69 M
MAVERICK CAPITAL LTD: 8.47 M
BlackRock, Inc.: 7.11 M
VANGUARD GROUP INC: 6.89 M
BioImpact Capital LLC: 3.9 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 3.84 M
87.08% of Rocket Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 243.87 M shares in the last 24 months. This purchase volume represents approximately $834.03 M in transactions.